Fate Therapeutics Inc. (FATE)
NASDAQ: FATE
· Real-Time Price · USD
1.01
0.04 (3.81%)
At close: Sep 05, 2025, 3:59 PM
1.01
0.00%
After-hours: Sep 05, 2025, 06:17 PM EDT
3.81% (1D)
| Bid | 0.94 |
| Market Cap | 116.48M |
| Revenue (ttm) | 8.47M |
| Net Income (ttm) | -171.52M |
| EPS (ttm) | -1.42 |
| PE Ratio (ttm) | -0.71 |
| Forward PE | -0.88 |
| Analyst | Hold |
| Ask | 1.05 |
| Volume | 1,661,666 |
| Avg. Volume (20D) | 1,679,467 |
| Open | 0.97 |
| Previous Close | 0.97 |
| Day's Range | 0.96 - 1.01 |
| 52-Week Range | 0.66 - 4.20 |
| Beta | 2.22 |
About FATE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol FATE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for FATE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Fate Therapeutics Inc. is scheduled to release its earnings on
Nov 11, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
+20.69%
Fate Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
4 months ago
+21.17%
Fate Therapeutics shares are trading higher after the FDA recently granted Regenerative Medicine Advanced Therapy designation to FT819.
